Charles Schwab Investment Management »

Neuropace shares owned by Charles Schwab Investment Management

Quarter-by-quarter ownership of Neuropace (NPCE) shares owned by Charles Schwab Investment Management from 13F filings

Historical chart of Charles Schwab Investment Management investment in Neuropace

Tip: Access up to 7 years of quarterly data

All positions including Neuropace held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neuropace by Charles Schwab Investment Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $710k 69k 10.31
2025-06-30 $767k 69k 11.14
2025-03-31 $482k 39k 12.29
2024-12-31 $409k 37k 11.19
2024-09-30 $255k 37k 6.97
2024-06-30 $276k 37k 7.56
2022-03-31 $140k 17k 8.25
2021-12-31 $176k 17k 10.09
2021-09-30 $277k 17k 15.88
2021-06-30 $416k 17k 23.84